You have 9 free searches left this month | for more free features.

Rutan

Showing 1 - 25 of 111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With COVID-19 Trial in Tashkent (The drug "Rutan 0.1"., Basic treatment)

Completed
  • Patients With COVID-19
  • The drug "Rutan 0.1".
  • Basic treatment
  • Tashkent, Uzbekistan
    Erkin Musabaev
May 15, 2023

COVID-19 Respiratory Infection Trial in Tashkent (Rutan 25 mg, Control group)

Completed
  • COVID-19 Respiratory Infection
  • Rutan 25 mg
  • Control group
  • Tashkent, Uzbekistan
    Tashkent Institute of Virology
May 16, 2023

Tranexamic Acid, Burns, Surgery Trial in Ars-Laquenexy, Lyon, Marseille (Tranexamic Acid, Placebo)

Active, not recruiting
  • Tranexamic Acid
  • +3 more
  • Tranexamic Acid
  • Placebo
  • Ars-Laquenexy, France
  • +3 more
Feb 8, 2022

Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Non-Hodgkin Lymphoma
  • +2 more
  • Mobile, Alabama
  • +189 more
Jan 28, 2023

Stroke Trial in Dallas (GWTG Stroke program)

Recruiting
  • Stroke
  • GWTG Stroke program
  • Dallas, Texas
    American Heart Association
Jun 4, 2020

Tranexamic Acid, Burn, Major Surgery Trial in Grand Rapids (Tranexamic Acid, Placebo Comparator)

Terminated
  • Tranexamic Acid
  • +2 more
  • Tranexamic Acid
  • Placebo Comparator
  • Grand Rapids, Michigan
    Spectrum Health Hospital
Aug 20, 2021

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Lung Cancer Trial in Australia, Canada, United States (lobectomy, segmentectomy or wedge resection)

Active, not recruiting
  • Lung Cancer
  • lobectomy
  • segmentectomy or wedge resection
  • Birmingham, Alabama
  • +385 more
Nov 17, 2022

Lymphoma Trial in United States (biological, drug, radiation)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +258 more
Sep 23, 2022

Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

Active, not recruiting
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Burbank, California
  • +340 more
Jan 28, 2023

Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)

Active, not recruiting
  • Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +5 more
  • Mobile, Alabama
  • +392 more
Jan 25, 2023

Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +363 more
Dec 30, 2022

Diabetic Foot Ulcer Trial in United States (AMNIOEXCEL Plus Amniotic Membrane, A Marketed Comparator, Standard of Care)

Completed
  • Diabetic Foot Ulcer
  • AMNIOEXCEL Plus Amniotic Membrane
  • +2 more
  • Fresno, California
  • +6 more
Jul 17, 2020

Heart Failure Trial in Dallas (GWTG Heart Failure program)

Recruiting
  • Heart Failure
  • GWTG Heart Failure program
  • Dallas, Texas
    American Heart Association
Jun 26, 2019

Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Pancreatic Neuroendocrine Tumor, Pancreatic Gastrinoma Trial in

Completed
  • Advanced Pancreatic Neuroendocrine Tumor
  • +5 more
  • Bevacizumab
  • +2 more
  • Mobile, Alabama
  • +393 more
Aug 3, 2022

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

Melanoma (Skin) Trial in Worldwide (interferon alfa-2b, observation)

Active, not recruiting
  • Melanoma (Skin)
  • interferon alfa-2b
  • observation
  • Birmingham, Alabama
  • +532 more
Jun 8, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +29 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +572 more
Jan 28, 2023

Breast Cancer Trial in United States (systemic chemo, axillary lymph node dissection, neoadjuvant therapy)

Active, not recruiting
  • Breast Cancer
  • systemic chemotherapy
  • +5 more
  • Mobile, Alabama
  • +323 more
Aug 16, 2021

Colon Mucinous Adenocarcinoma, Colon Signet Ring Cell Adenocarcinoma, Lynch Syndrome Trial in Worldwide (biological, drug,

Active, not recruiting
  • Colon Mucinous Adenocarcinoma
  • +5 more
  • Bevacizumab
  • +4 more
  • Anniston, Alabama
  • +935 more
Oct 18, 2022

Malignant Mesothelioma Trial in United States (everolimus)

Completed
  • Malignant Mesothelioma
  • Tucson, Arizona
  • +128 more
Feb 19, 2020

Lung Cancer Trial in United States (bevacizumab, erlotinib HCl)

Completed
  • Lung Cancer
  • bevacizumab
  • erlotinib hydrochloride
  • Antioch, California
  • +147 more
Mar 20, 2020

Advanced Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7 Trial in

Completed
  • Advanced Adult Hepatocellular Carcinoma
  • +9 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Birmingham, Alabama
  • +672 more
Aug 3, 2022

Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • Laboratory Biomarker Analysis
  • +2 more
  • Anniston, Alabama
  • +1267 more
Jan 28, 2023

Lung Cancer Trial in United States (cisplatin, gemcitabine HCl)

Completed
  • Lung Cancer
  • Fort Smith, Arkansas
  • +146 more
Feb 19, 2020